NFA
INFI

Nationwide Fund Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Nationwide Fund Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-49,500
Closed -$66K – 2348
2017
Q3 		$66K Sell
49,500
-16,338
-25% -$20.3K ﹤0.01% 3010
2017
Q2 		$103K Sell
65,838
-31,080
-32% -$59.9K ﹤0.01% 2886
2017
Q1 		$313K Buy
96,918
+65,838
+212% +$162K ﹤0.01% 2395
2016
Q4 		$42K Hold
31,080
– – ﹤0.01% 3030
2016
Q3 		$48K Hold
31,080
– – ﹤0.01% 3054
2016
Q2 		$41K Sell
31,080
-42,175
-58% -$197K ﹤0.01% 3101
2016
Q1 		$386K Sell
73,255
-3,739
-5% -$22.9K ﹤0.01% 2224
2015
Q4 		$604K Buy
76,994
+252
+0.3% +$2.17K ﹤0.01% 2013
2015
Q3 		$648K Sell
76,742
-2,050
-3% -$18.9K ﹤0.01% 1950
2015
Q2 		$863K Buy
78,792
+27,371
+53% +$351K ﹤0.01% 1943
2015
Q1 		$719K Sell
51,421
-1,019
-2% -$15.6K ﹤0.01% 2063
2014
Q4 		$886K Buy
52,440
+14,990
+40% +$218K ﹤0.01% 1870
2014
Q3 		$503K Buy
37,450
+93
+0.2% +$1.11K ﹤0.01% 2215
2014
Q2 		$476K Buy
37,357
+362
+1% +$3.77K ﹤0.01% 2285
2014
Q1 		$440K Sell
36,995
-23,420
-39% -$314K ﹤0.01% 2113
2013
Q4 		$834K Sell
60,415
-1,053
-2% -$14.9K ﹤0.01% 1974
2013
Q3 		$1.07M Buy
61,468
+32,996
+116% +$632K ﹤0.01% 1810
2013
Q2 		$463K Buy
+28,472
New +$881K ﹤0.01% 2050

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nationwide Fund Advisors's INFI Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2017, closing a stake of 49,500 shares — an estimated $66K sold.

Nationwide Fund Advisors first reported a position in INFI in Q2 2013 and held it in 18 quarters. The position peaked at $1.07M in Q3 2013. 65 funds tracked by Wall St. Rank hold INFI as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 49,500 Infinity Pharmaceuticals, Inc. shares in Q4 2017, an estimated $66K.
  • Nationwide Fund Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Infinity Pharmaceuticals, Inc. position peaked at $1.07M in Q3 2013.
  • 65 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.